JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drosten, C.
Right arrow Articles by Koay, E. S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drosten, C.
Right arrow Articles by Koay, E. S. C.
Journal of Clinical Microbiology, May 2004, p. 2043-2047, Vol. 42, No. 5
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.5.2043-2047.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus

Christian Drosten,1* Lily-Lily Chiu,2 Marcus Panning,1 Hoe Nam Leong,3 Wolfgang Preiser,4 John S. Tam,5 Stephan Günther,1 Stefanie Kramme,1 Petra Emmerich,1 Wooi Loon Ng,2,6 Herbert Schmitz,1 and Evelyn S. C. Koay2,6

Department of Virology, Bernhard-Nocht Institute for Tropical Medicine, Hamburg,1 Institute of Medical Virology, Johann-Wolfgang-Goethe University, Frankfurt, Germany,4 Molecular Diagnosis Centre, Department of Laboratory Medicine, National University Hospital,2 Department of Infectious Diseases, Tan Tock Seng Hospital,3 Department of Pathology, National University of Singapore, Singapore,6 Department of Microbiology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People’s Republic of China5

Received 10 October 2003/ Returned for modification 14 December 2003/ Accepted 14 February 2004

First-generation reverse transcription-PCR (RT-PCR) assays for severe acute respiratory syndrome-associated coronavirus (SARS-CoV) gave false-negative results in a considerable fraction of patients. In the present study, we evaluated two second-generation, replicase (R) gene-based, real-time RT-PCR test kits—the RealArt HPA coronavirus LC kit (Artus, Hamburg, Germany) and the LightCycler SARS-CoV quantification kit (Roche, Penzberg, Germany)—and a real-time RT-PCR assay for the nucleocapsid (N) gene. Detecting the N-gene RNA might be advantageous due to its high abundance in cells. The kits achieved sensitivities of 70.8% (Artus) and 67.1% (Roche) in 66 specimens from patients with confirmed SARS (samples primarily from the upper and lower respiratory tract and stool). The sensitivity of the N-gene assay was 74.2%. The differences in all of the sensitivities were not statistically significant (P = 0.680 [analysis of variance]). Culture cells initially contained five times more N- than R-gene RNA, but the respective levels converged during 4 days of virus replication. In clinical samples the median concentrations of R- and N-gene RNA, respectively, were 1.2 x 106 and 2.8 x 106 copies/ml (sputum and endotracheal aspirates), 4.3 x 104 and 5.5 x 104 copies/ml (stool), and 5.5 x 102 and 5.2 x 102 copies/sample (throat swabs and saliva). Differences between the samples types were significant but not between the types of target RNA. All (n = 12) samples from the lower respiratory tract tested positive in all tests. In conclusion, the novel assays are more sensitive than the first-generation tests, but they still do not allow a comprehensive ruling out of SARS. Methods for the routine sampling of sputum without infection risk are needed to improve SARS RT-PCR.


* Corresponding author. Mailing address: Bernhard-Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, 20359 Hamburg, Germany. Phone: 49-40-42818-421. Fax: 49-40-42818-378. E-mail: drosten{at}bni-hamburg.de.


Journal of Clinical Microbiology, May 2004, p. 2043-2047, Vol. 42, No. 5
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.5.2043-2047.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.